These findings are the result of research Canadian and American scientists. In this study, they tested it on mice.
Since 2007 in Germany is going a combined therapy of the drug pioglitazone with insulin. First interim analysis was recently published. These indicate that the combination in the future is both effective and safe.
The type 2 diabetes
Type-2 diabetes have a resistance of body cells to the biological effects of insulin. Once this so-called insulin resistance is too strong, does the injected insulin in a diabetes therapy is not effective enough. Be increased in these cases, the insulin sensitivity by insulin sensitizers. These sensitizers are firstly used for type-2 diabetes with marked insulin resistance, ie, in patients in whom insulin alone is insufficient. On the other hand in diabetic patients who are not the standard combination of insulin and metformin because of contraindications or intolerance can take.
© 2010 Diabetes Treatment Weblog. All right reserved.